P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas von Rousso-Noori, Liat, Mastandrea, Ignacio, Talmor, Shauli, Waks, Tova, Globerson Levin, Anat, Haugas, Maarja, Teesalu, Tambet, Alvarez-Vallina, Luis, Eshhar, Zelig, Friedmann-Morvinski, Dinorah

Volltext

Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach von Globerson Levin, Anat, Kronik, Natalie, Shiloach, Tamar, Waks, Tova, Eshhar, Zelig, Vainstein, Vladimir

Volltext

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer von KERSHAW, Michael H, WESTWARD, Jennifer A, CHEN, Clara C, YANG, James C, ROSENBERG, Steven A, HWU, Patrick, PARKER, Linda L, GANG WANG, ESHHAR, Zelig, MAVROUKAKIS, Sharon A, WHITE, Donald E, WUNDERLICH, John R, CANEVARI, Silvana, ROGERS-FREEZER, Linda

Volltext

Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy von Gross, Gideon, Eshhar, Zelig

Volltext

Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide von PAPO, Niv, SEGER, Dalia, MAKOVITZKI, Arik, KALCHENKO, Vyacheslav, ESHHAR, Zelig, DEGANI, Hadassa, SHAI, Yechiel

Volltext

From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells von Eshhar, Zelig

Volltext

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells von Blat, Dan, Zigmond, Ehud, Alteber, Zoya, Waks, Tova, Eshhar, Zelig

Volltext

Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice von Elinav, Eran, Waks, Tova, Eshhar, Zelig

Volltext

Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells von Globerson-Levin, Anat, Waks, Tova, Eshhar, Zelig

Volltext

CAR T cells: Building on the CD19 paradigm von Globerson Levin, Anat, Rivière, Isabelle, Eshhar, Zelig, Sadelain, Michel

Volltext

CAR's made it to the pancreas von Chmielewski, Markus, Maliar, Amit, Eshhar, Zelig, Abken, Hinrich

Volltext

Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity von Kochupurakkal, Bose S., Harari, Daniel, Di-Segni, Ayelet, Maik-Rachline, Galia, Lyass, Ljuba, Gur, Gal, Kerber, Gabriele, Citri, Ami, Lavi, Sara, Eilam, Raya, Chalifa-Caspi, Vered, Eshhar, Zelig, Pikarsky, Eli, Pinkas-Kramarski, Ronit, Bacus, Sarah S., Yarden, Yosef

Volltext

Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies von Szöőr, Árpád, Tóth, Gábor, Zsebik, Barbara, Szabó, Viktória, Eshhar, Zelig, Abken, Hinrich, Vereb, György

Volltext

The emergence of T-bodies/CAR T cells von Eshhar, Zelig, Waks, Tova, Gross, Gideon

Volltext

Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor von Elinav, Eran, Adam, Nitzan, Waks, Tova, Eshhar, Zelig

Volltext

Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice von Maliar, Amit, Servais, Charlotte, Waks, Tova, Chmielewski, Markus, Lavy, Ron, Altevogt, Peter, Abken, Hinrich, Eshhar, Zelig

Volltext

Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds von Oren, Ravit, Hod-Marco, Moran, Haus-Cohen, Maya, Thomas, Sharyn, Blat, Dan, Duvshani, Nerri, Denkberg, Galit, Elbaz, Yael, Benchetrit, Fabrice, Eshhar, Zelig, Stauss, Hans, Reiter, Yoram

Volltext

Allogeneic Veto-CAR CD8 T Cells Enabling Prolonged Graft Survival, Anti-Tumor Specificity, and Low Risk of Graft Versus Host Disease von Liu, Wei-Hsin, Globerson Levin, Anat, Lask, Assaf, Horn, Galit, Waks, Tova, Nathansohn Levy, Bar, Mamonkin, Maksim, Eshhar, Zelig, Champlin, Richard E., Reisner, Yair, Bachar Lustig, Esther

Volltext

Redirected tumor-specific allogeneic T cells for universal treatment of cancer von Marcus, Assaf, Waks, Tova, Eshhar, Zelig

Volltext

Photodynamic Therapy of Established Prostatic Adenocarcinoma with TOOKAD: A Biphasic Apparent Diffusion Coefficient Change as Potential Early MRI Response Marker von Plaks, Vicki, Koudinova, Natalia, Nevo, Uri, Pinthus, Jehonathan H., Kanety, Hannah, Eshhar, Zelig, Ramon, Jacob, Scherz, Avigdor, Neeman, Michal, Salomon, Yoram

Volltext